Medical Product Alert N°1/2025: Falsified (contaminated) OXYCONTIN 80mg

Published on March 24, 2025

Falsified (contaminated) OXYCONTIN 80mg identified in the WHO European Region

Alert Summary 

This WHO Medical Product Alert refers to one batch of falsified OXYCONTIN 80mg (oxycodone hydrochloride). The falsified product was detected in the unregulated market in Switzerland and reported to WHO in February 2025 by the genuine manufacturer MUNDIPHARMA. The falsified product imitates genuine OXYCONTIN 80mg authorized in Poland.

OXYCONTIN (oxycodone hydrochloride) is a semi-synthetic opioid indicated for the treatment of moderate to severe pain.

Laboratory testing of samples of the falsified product was conducted by the Drug Information Centre of the City of Zurich (DIZ), Switzerland. DIZ’s drug checking service determined that the tablets did not contain oxycodone, but a synthetic opioid likely to be a nitazene compound.

Read the full story on the WHO website

Other news

Many pregnancy-related complications going undetected and untreated – WHO

March 24, 2025
Haemorrhage – severe heavy bleeding – and hypertensive disorders like preeclampsia are the leading causes of maternal deaths globally, according to a new study released today by the World Health Organization (WHO). These conditions were responsible for around 80 000 and 50 000 fatalities respectively in 2020 – the last year for which published estimates are available - highlighting that many women

WHO flash appeal: earthquake response in Myanmar

March 31, 2025
Two powerful earthquakes have devastated central Myanmar, disrupting health services and putting thousands at risk of life-threatening injuries and disease outbreaks. WHO is responding at its highest level of emergency activation – deploying nearly three tonnes of emergency medical supplies within 24 hours and coordinating global Emergency Medical Teams.WHO urgently needs US$ 8 million to deliver